20. |
Non-controlling interest (NCI) |
On April 20, 2015 the Company acquired 100% of the shares of DCA, which owns 74.5% of the shares of MBJA and the remaining 25.5% is Vantage as a non-controlling shareholder.
On March 23, 2017, the Board of Directors of MBJA approved a dividend payment from retained earnings in the amount of USD$26.0 million, which will be distributed as follows: U.S.$19.37 million to DCA (Ps. 382,275 a closing exchange rate of Ps. 19.7354) and U.S.$6.63 million to Vantage (Ps. 130,846 closing exchange rate).
The following table summarizes the information relating to DCA that has material NCI, before any intra-group elimination as of December 31:
|
|
2015 |
|
|
2016 |
|
|
2017 |
|
||||||
NCI percentage |
|
25.5% |
|
|
25.5% |
|
|
25.5% |
|
||||||
Non-current assets |
|
Ps. |
|
5,329,086 |
|
|
Ps. |
|
6,117,021 |
|
|
Ps. |
|
5,610,289 |
|
Current assets |
|
|
|
529,288 |
|
|
|
|
1,155,778 |
|
|
|
|
1,505,069 |
|
Non-current liabilities |
|
|
|
(2,073,551 |
) |
|
|
|
(2,590,361 |
) |
|
|
|
(1,840,532 |
) |
Current liabilities |
|
|
|
(325,640 |
) |
|
|
|
(480,267 |
) |
|
|
|
(1,162,848 |
) |
Net assets |
|
|
|
3,459,183 |
|
|
|
|
4,202,171 |
|
|
|
|
4,111,978 |
|
Net assets attributable to NCI |
|
Ps. |
|
882,092 |
|
|
Ps. |
|
1,071,554 |
|
|
Ps. |
|
1,048,554 |
|
|
|
2015 |
|
|
2016 |
|
|
2017 |
|
||||||
Revenue |
|
Ps. |
|
995,707 |
|
|
Ps. |
|
1,622,033 |
|
|
Ps. |
|
1,852,687 |
|
Profit |
|
|
|
175,518 |
|
|
|
|
281,078 |
|
|
|
|
321,416 |
|
OCI |
|
|
|
482,394 |
|
|
|
|
773,453 |
|
|
|
|
(225,169 |
) |
Total comprehensive income |
|
|
|
875,237 |
|
|
|
|
992,944 |
|
|
|
|
96,247 |
|
Profit allocated to NCI |
|
|
|
44,757 |
|
|
|
|
71,675 |
|
|
|
|
81,961 |
|
OCI allocated to NCI |
|
Ps. |
|
66,901 |
|
|
Ps. |
|
117,787 |
|
|
Ps. |
|
(31,635 |
) |
|
|
2015 |
|
|
2016 |
|
|
2017 |
|
||||||
Net cash provided by operating activities |
|
|
|
761,724 |
|
|
|
|
729,858 |
|
|
|
|
625,619 |
|
Net cash provided by investment activities |
|
|
|
7,959 |
|
|
|
|
13,673 |
|
|
|
|
(122,417 |
) |
Net cash used in financing activities |
|
|
|
(346,807 |
) |
|
|
|
(156,099 |
) |
|
|
|
(202,264 |
) |
Net increase in cash and cash equivalents |
|
Ps. |
|
422,876 |
|
|
Ps. |
|
587,432 |
|
|
Ps. |
|
300,938 |
|